People with dementia and their carers in Surrey and North East Hampshire will benefit from an innovative new project that will use technology to revolutionize healthcare. A variety of apps, monitors, sensors and other devices will be combined in an ‘Internet of Things’ that will monitor people’s health in their own homes. These devices will produce information to help people with dementia and their carers take more control over their own health and wellbeing. The insights and alerts provided by the combination of devices will enable healthcare staff to deliver more responsive and effective services. The ‘Test Bed’ project is funded by Innovate UK and NHS England to try out combinations of technologies that have the potential to improve care quality and provide better value for money. The project is led by Surrey & Borders NHS Foundation Trust working with the University of Surrey, Royal Holloway, University of London, Kent, Surrey and Sussex Academic Health Science Network, the Alzheimer’s Society, local Clinical Commissioning Groups, charities and other partners.

People with dementia and their carers in Surrey and North East Hampshire will benefit from an innovative new project that will use technology to revolutionize healthcare. A variety of apps, monitors, sensors and other devices will be combined in an ‘Internet of Things’ that will monitor people’s health in their own homes. These devices will produce information to help people with dementia and their carers take more control over their own health and wellbeing. The insights and alerts provided by the combination of devices will enable healthcare staff to deliver more responsive and effective services. The ‘Test Bed’ project is funded by Innovate UK and NHS England to try out combinations of technologies that have the potential to improve care quality and provide better value for money. The project is led by Surrey & Borders NHS Foundation Trust working with the University of Surrey, Royal Holloway, University of London, Kent, Surrey and Sussex Academic Health Science Network, the Alzheimer’s Society, local Clinical Commissioning Groups, charities and other partners.